Skip to content

James Christensen

President at Terremoto Biosciences.

Earliest Form D on file: Apr 2026

Filed Apr 22, 2026

Terremoto Biosciences

Selective AKT1 inhibitors for breast cancer and solid tumors

Biotech, South San Francisco CA

Signed as President

$40.725M

sold of $108.6M offered

Form D

LinkedIn

Network

At Terremoto Biosciences

6 people